奥洛兹美医疗与欧如卡公司联合宣布,双方已签署一项全球性的合作与授权协议。该协议的核心内容,是围绕利用奥洛兹美医疗专有的Hypercon™药物递送技术,共同推进欧如卡旗下在研药物Orka-001的开发工作。此次合作旨在结合双方在技术平台与药物研发领域的专长,加速创新疗法的问世。
奥洛兹美医疗与欧如卡公司联合宣布,双方已签署一项全球性的合作与授权协议。该协议的核心内容,是围绕利用奥洛兹美医疗专有的Hypercon™药物递送技术,共同推进欧如卡旗下在研药物Orka-001的开发工作。此次合作旨在结合双方在技术平台与药物研发领域的专长,加速创新疗法的问世。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.